96 related articles for article (PubMed ID: 7276564)
1. The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing latephase reactions.
Oertel HL; Kaliner M
J Immunol; 1981 Oct; 127(4):1398-402. PubMed ID: 7276564
[No Abstract] [Full Text] [Related]
2. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin.
Tannenbaum S; Oertel H; Henderson W; Kaliner M
J Immunol; 1980 Jul; 125(1):325-35. PubMed ID: 6966657
[No Abstract] [Full Text] [Related]
3. IgE immunoglobulin in the rabbit. The histopathology of the homologous passive cutaneous anaphylaxis reaction.
Bauer H; Zvaifler NJ; Robinson JO
Lab Invest; 1972 Apr; 26(4):448-58. PubMed ID: 5021014
[No Abstract] [Full Text] [Related]
4. The biologic activity of mast cell granules in rat skin: effects of adrenocorticosteroids on late-phase inflammatory responses induced by mast cell granules.
Oertel H; Kaliner M
J Allergy Clin Immunol; 1981 Sep; 68(3):238-45. PubMed ID: 6267116
[No Abstract] [Full Text] [Related]
5. The platelet as an inflammatory cell.
Nachman RL; Weksler B
Ann N Y Acad Sci; 1972 Oct; 201():131-7. PubMed ID: 4119234
[No Abstract] [Full Text] [Related]
6. [MCD-peptide from bee venom: isolation, biochemical and pharmacolgical properties].
Breithaupt H; Habermann E
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(3):252-70. PubMed ID: 4235474
[No Abstract] [Full Text] [Related]
7. The biologic activity of mast cell granules. VI. The effect of vinblastine-induced neutropenia on rat cutaneous late phase reactions.
Lemanske RF; Guthman DA; Oertel H; Barr L; Kaliner M
J Immunol; 1983 Jun; 130(6):2837-42. PubMed ID: 6854018
[TBL] [Abstract][Full Text] [Related]
8. [Amino acid sequence of MCD-peptide, a specific mast cell-degranulating peptide from bee venom].
Haux P
Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):536-46. PubMed ID: 5789872
[No Abstract] [Full Text] [Related]
9. The rat mast cell degranulation test as applied to a case of severe food allergy.
Maclaren WR; Ho FC; Lopapa A
Ann Allergy; 1972 Jan; 30(1):41-4. PubMed ID: 5061697
[No Abstract] [Full Text] [Related]
10. [Isolation of histamine liberating and vascular permeability increasing polypeptides from lysosomal granules of polymorphonuclear leukocytes in circulating bovine blood].
Frimmer M; Lutz F
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(2):297-313. PubMed ID: 4181231
[No Abstract] [Full Text] [Related]
11. Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity.
Boswell RN; Austen KF; Goetzl EJ
J Immunol; 1978 Jan; 120(1):15-20. PubMed ID: 24070
[No Abstract] [Full Text] [Related]
12. Purification and partial characterization of hypocalcemic factor from human saliva.
Bonilla CA; Stringham RM
Prep Biochem; 1972; 2(4):305-28. PubMed ID: 5083268
[No Abstract] [Full Text] [Related]
13. HPLC methods for purification of antimicrobial peptides.
Selsted ME
Methods Mol Biol; 1997; 78():17-33. PubMed ID: 9276294
[No Abstract] [Full Text] [Related]
14. The initiation of mast cell degranulation: activation at the cell membrane.
Morrison DC; Roser JF; Cochrane CG; Henson PM
J Immunol; 1975 Mar; 114(3):966-70. PubMed ID: 163282
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mast-cell degranulation by chemotactic peptides.
Gleisner JM; Ramthun CA; Houck JC
Inflammation; 1981 Mar; 5(1):13-7. PubMed ID: 7228352
[TBL] [Abstract][Full Text] [Related]
16. Basic proteins in rat neutrophils that increase vascular permeability.
Ranadive NS; Cochrane CG
Clin Exp Immunol; 1970 Jun; 6(6):905-11. PubMed ID: 4097809
[TBL] [Abstract][Full Text] [Related]
17. The biologic activity of mast cell granules. IV. The effect of complement depletion on rat cutaneous late phase reactions.
Lemanske RF; Joiner K; Kaliner M
J Immunol; 1983 Apr; 130(4):1881-4. PubMed ID: 6220070
[TBL] [Abstract][Full Text] [Related]
18. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF).
Cruikshank W; Center DM
J Immunol; 1982 Jun; 128(6):2569-74. PubMed ID: 7042841
[No Abstract] [Full Text] [Related]
19. Mast cells and mast cell-sensitizing (homocytotropic) antibodies.
Bloch KJ; Angevine C
Rheumatology; 1970; 3():169-93. PubMed ID: 5003462
[No Abstract] [Full Text] [Related]
20. [Mast cells and vascular permeability in experimental aseptic peritonitis in the rat].
Chernukh AM; Alekseev OV; Vasadze OG
Biull Eksp Biol Med; 1981 May; 91(5):528-30. PubMed ID: 7260375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
